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Abstract Gum kondagogu reduced/stabilized silver
nanoparticles (GK-AgNPs) were evaluated for their
increased antibacterial and antibiofilm activities in com-
bination with various antibiotics (ciprofloxacin, strepto-
mycin and gentamicin) against Gram-positive
(Staphylococcus aureus 25923, Staphylococcus aureus
49834) and Gram-negative (Escherichia coli 25922,
Pseudomonas aeruginosa 27853) bacteria. The micro-broth
dilution assay suggested an enhanced antibacterial activity
of GK-AgNPs in combination with ciprofloxacin and
aminoglycosides (streptomycin and gentamicin) against
tested strains. Though the antibacterial activity of GK-
AgNPs was found to increase significantly in the presence
of antibiotics, the % enhancement was found to depend on
both types of antibiotic and bacterial strain. It was also
found that GK-AgNPs (1 lg/mL) in combination with
various antibiotics at sub-MIC concentrations could inhibit
70 % of the bacterial biofilm formation as compared to
respective controls. The enhanced antibacterial activity
was due to the increased production of intracellular reac-
tive oxygen species in bacteria when treated with a com-
bination of GK-AgNPs and streptomycin as compared to
individual treatment. The increased oxidative stress led to
increased membrane damage as assessed by live/dead
assay and higher levels of potassium ion release from
the cells treated with both silver nanoparticles and
streptomycin. The results suggested that the combination of
antibiotics with GK-AgNPs has an enhanced antibacterial
action. Further, the GK-AgNPs were found to be biocom-
patible up to a concentration of 2.5 lg/mL as assessed with
MTT assay on HeLa cell line. The results suggest that GK-
AgNPs could potentially be used as in vivo antibacterial
agent in combination with antibiotics to overcome the
problem of antibiotic resistance.
Keywords Antibacterial  Antibiofilm  Antibiotics 
Gum kondagogu  Reactive oxygen species  Silver
nanoparticles
Introduction
Resistance to antibiotics by pathogenic bacteria and fungi
has been increasing at a disquieting rate and has become a
serious problem, e.g., bacteria like E. coli and S. typhi have
been reported to exhibit resistance to a variety of antibiotics
(Wright 2005). Researchers worldwide have been trying to
develop new, cost-effective and resistance-free effective
antimicrobial agents, due to the prevalence of resistant or
even multi-resistant pathogens and the continuing stress on
health care costs (Gelatti et al. 2009). There are several
examples of silver being widely used as an effective anti-
microbial agent since ancient times (Rai et al. 2009). The
antimicrobial activity of silver nanoparticles (AgNPs), in
particular, is of significant interest because it was found to be
effective against even multidrug resistance organisms (Ay-
ala-Nu´n˜ez and Villegas 2009). The silver nanoparticles are
found to have broad spectrum activity and far lower pro-
pensity to inducemicrobial resistance than antibiotics (Inoue
et al. 2002). These advantages have led to renaissance of
AgNPs-based products like: wound dressings (Maneerung
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et al. 2008), antiseptic creams, water filters (Jain and Pradeep
2005), fabrics (Zhang et al. 2009), etc. However, toxicity
issues have led to the limited use of bactericidal silver in nano
form and needs to be investigated (Miura and Shinohara
2009). In this context, an alternative and intelligent approach
is to effectively use AgNPs in combination with antibiotics
so as to achieve desired antimicrobial potential at safe levels
of both nano silver and antibiotics. In the recent past, many
studies have been carried out to investigate the combina-
torial/synergistic effect of AgNPs and antibiotics. It was
reported that when amoxicillin and AgNPs are combined, it
results in greater bactericidal efficiency on E. coli cells than
when they were applied separately (Ping et al. 2005). In
another study, the antibacterial activities of ampicillin,
kanamycin, erythromycin, and chloramphenicol were found
to increase in the presence of AgNPs against test strains
(Fayaz et al. 2010). Similarly, the antifungal activity of
fluconazole was enhanced in the presence of AgNPs against
the test fungi (Gajbhiye et al. 2009). The main aim of this
study is to investigate the combined effect of natural gum
synthesized AgNPs with various antibiotics on both Gram
classes of bacteria. In a previous study by our laboratory, we
have reported a facile, eco-friendly method for the synthesis
of gum kondagogu (Cochlospermum gossypium) reduced/
stabilized silver nanoparticles (GK-AgNPs). The influence
of different parameters: gum particle size, concentration of
gum, concentration of silver nitrate and reaction time on the
synthesis of nanoparticles was studied. At the optimized
reaction conditions, it was possible to synthesize nearly
monodispersed and size-controlled spherical AgNPs. Using
well-diffusion assay, the antibacterial potential of GK-Ag-
NPswas also demonstrated on bothGram classes of bacteria.




Gum kondagogu, grade-1 (Girijan Co-operative Corpora-
tion, Hyderabad, India), Silver nitrate (E. Merck, Mumbai,
India), ciprofloxacin hydrochloride, streptomycin sulfate,
gentamicin sulfate (Himedia, Mumbai, India), 2,7-dichlor-
odihydrofluorescein diacetate (H2DCFDA) (Sigma, Ben-
galuru, India) and LIVE/DEAD BacLight bacterial viability
kit L7012 (Molecular probes, Eugene, USA) were used.
Synthesis and characterization of gum kondagogu
reduced/stabilized silver nanoparticles (GK-AgNPs)
The GK-AgNPs were prepared as reported earlier by us
(Kora et al. 2010). Briefly, dried gum kondagogu tears
were powdered in a high-speed mechanical blender
(Prestige, Bengaluru, India) and sieved to obtain a mean
particle size of 38 lm. A 1.0 % (w/v) of homogenous
gum stock solution was prepared in ultrapure water by
stirring overnight at room temperature. The AgNPs were
synthesized by autoclaving the 1 mM silver nitrate solu-
tions containing 0.5 % of gum at 121 C and 15 psi for
60 min. The synthesized GK-AgNPs were drop coated on
a carbon-coated copper grid and subjected to transmission
electron microscopy (TEM) (Philips CM200, The Neth-
erlands) for determination of size and shape. The zeta
potential of the nanoparticle solution was measured using
a Malvern Zetasizer Nano ZS90 (Worcestershire, UK).




For determining the minimum inhibitory concentration
(MIC) of GK-AgNPs and antibiotics, the micro-broth
dilution method (Martinez-Castanon et al. 2008) was
used. Staphylococcus aureus ATCC 25923 and Staphy-
lococcus aureus ATCC 49834, and Escherichia coli
ATCC 25922 and Pseudomonas aeruginosa ATCC
27853 were used as model test strains for Gram-positive
and Gram-negative bacteria, respectively. The assay was
performed in a 96-well microtitre plate where the
nutrient broth was supplemented with different concen-
trations of nanoparticles (1–10 lg/mL) and antibiotics:
ciprofloxacin (0.05–0.5 lg/mL), streptomycin and gen-
tamicin (0.1–5 lg/mL) followed by inoculation with
bacterial cell suspension to obtain 106 CFU/mL. The
control wells were maintained without any treatment.
The MIC was determined after 48 h of static incubation
at 37 C by measuring the absorbance of these culture
broths at 600 nm using a Biotek SynergyTM H1 plate
reader (Bad Friedrichshall, Germany). To evaluate the
synergism between GK-AgNPs and various antibiotics,
the sub-MIC concentrations of both GK-AgNPs and
antibiotics were added to the wells followed by inocu-
lation with bacterial suspension of 106 CFU/mL. The
occurrence and degree of synergism were checked by
quantifying the fractional inhibitory concentration (FIC)
index as reported earlier (Ghosh et al. 2013). The frac-
tional inhibitory concentration (FIC) index = MIC of
GK-AgNPs in combination with antibiotic/MIC of GK-
AgNPs alone ? MIC of antibiotic in combination with
GK-AgNPs/MIC of antibiotic alone. If the FIC index
B0.5, the effect is synergistic, while the value is
0.5\ FIC B 1.0 it is additive and a value of FIC[1.0 is
indifferent.
536 Appl Nanosci (2015) 5:535–543
123
Assay for inhibition of biofilm formation
A modified microtitre plate assay (Uhlich et al. 2006) was
performed to see the combinatorial effect of GK-AgNPs
and antibiotics on biofilm formation. In brief, sterile,
polystyrene microtitre plate wells were inoculated with
200 lL of nutrient broth containing 106 CFU/mL and
treated with GK-AgNPs and antibiotics separately and in
combination followed by incubation at 37 C. The negative
and positive controls were maintained with untreated and
70 % ethanol (50 lL/mL) treated cells, respectively. After
48 h of incubation, the medium in the wells was removed
and washed with sterile phosphate-buffered saline (PBS) to
remove the loosely attached bacteria. The wells were then
stained with 200 lL of 0.1 % crystal violet for 30 min at
37 C. Further, these wells were washed, air dried, the
bound stain was solubilized in 200 lL of 95 % ethanol and
the absorbance was recorded using a Biotek SynergyTM H1
micro-plate reader (Bad Friedrichshall, Germany) at
590 nm.
Measurement of intracellular reactive oxygen species
(ROS)
For assessment of intracellular ROS (Choi and Hu 2008),
exponentially grown cells were obtained by inoculating the
overnight grown bacterial cell suspension (106 CFU/mL) in
fresh nutrient broth and incubating at 37 C, 65 rpm for
4 h. Then, the cells were collected by centrifugation
(5,5009g, 10 min), followed by washing and resuspending
in PBS. Further, the cells were labeled with 10 lM
H2DCFDA (20 min, 37 C) followed by treatment (1 h,
37 C) with GK-AgNPs (2 lg/mL) and streptomycin
(0.5 lg/mL). The negative and positive controls were
maintained with untreated and 70 % ethanol (50 lL/mL)
treated cells, respectively. The cells were washed with PBS
and the fluorescence intensity was measured using a fluo-
rescence plate reader with excitation and emissions at 490
and 520 nm, respectively.
Measurement of cytoplasmic potassium ion leakage
The K? leakage analysis (Tiwari et al. 2008) of GK-
AgNPs and streptomycin treated bacterial cells was done
to evaluate the combined effect on bacterial membrane.
The cells in exponential grown phase were obtained as
detailed in ‘‘Measurement of intracellular reactive oxygen
species (ROS)’’. Later, the cells were treated with GK-
AgNPs (2 lg/mL) and streptomycin (0.5 lg/mL) in PBS
followed by incubation at 37 C for 4 h. The negative and
positive controls were maintained with untreated and
70 % ethanol (50 lL/mL) treated cells, respectively. The
cells were centrifuged (5,5009g, 10 min) and the col-
lected supernatants were analyzed for potassium content
by a Jobin–Yvon Horiba JY-2000 ICP-OES (Longjumeau,
France).
Live/dead assay
The synergistic effect of GK-AgNPs and streptomycin was
also assessed with exponentially grown cells as described
in ‘‘Measurement of intracellular reactive oxygen species
(ROS)’’, using Live/dead assay (Chamakura et al. 2011).
For this, the P. aeruginosa 27853 cells were treated with
GK-AgNPs (2 lg/mL) and streptomycin (0.5 lg/mL) for
4 h. Later, the cells were washed, resuspended in PBS and
stained with LIVE/DEAD BacLight bacterial viability kit
as per manufacturer’s instructions. The negative and
positive controls were maintained with untreated and 70 %
ethanol (50 lL/mL) treated cells, respectively. An aliquot
of the stained cells was dropped on the glass slides and
observed under LM-52-3001 Lawrence and Mayo epi-
fluorescence microscope (Mumbai, India) under green fil-
ter. The digital images of the bacterial cells were captured
using a Coolpix P6000 Nikon digital camera (Tokyo,
Japan) attached to the microscope.
In vitro cytotoxicity assay
The HeLa cell cultures were maintained in DMEM with
10 % fetal calf serum. For cell toxicity tests, 2 9 105 cells
at the exponential growth phase were seeded in each well
of 96-well microtitre plates and incubated in an INC 108
Memmert CO2 incubator (Schwabach, Germany) (5 %
CO2, 37 C). A series of dilutions containing 1.0, 2.5, 5.0
and 10 lg/mL of GK-AgNPs were dispensed into the wells
of microtitre plate. The negative and positive controls were
maintained with untreated and doxorubicin (13 lg/mL)
treated cells, respectively. The cell viability was measured
at 48 h post-incubation using MTT (3-(4,5-dimeth-
yathiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay.
The assay was based on the measurement of the mito-
chondrial activity of viable cells by the reduction of tet-
razolium salt to form a blue water-insoluble product,
formazan (Cao et al. 2010). After 48 h of incubation, the
MTT (5 mg/mL) was added to the cells and the plates were
incubated for additional 4 h. Later, the medium was
removed and 200 lL of DMSO was added to dissolve the
formazan crystals. The absorbance of dissolved formazan
was measured at 540 nm using a Biotek SynergyTM H1
plate reader (Bad Friedrichshall, Germany). The absor-
bance was directly correlated with the number of viable
cells and was used to calculate the percentage viability.
Appl Nanosci (2015) 5:535–543 537
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Statistical analysis
Three independent experiments were carried out and the
results are represented as mean ± SD. The Student’s t test




The TEM analysis revealed that the AgNPs synthesized
with 0.5 % gum and 1 mM silver nitrate by 60 min of
autoclaving; the nanoparticles synthesized were spherical
in shape, with an average size of 5.8 ± 2.4 nm (Kora et al.
2010). The presence of concentric rings with intermittent
bright dots in selected-area electron diffraction (SAED)
pattern indicated the crystalline nature of the particles. The
zeta potential of the synthesized nanoparticles was found to
be -30.3 ± 4.1 mV, suggesting the stable nature of the
GK-AgNPs (Fig. 1).
Micro-broth dilution assay
From the micro-broth dilution assay, the MIC of the Ag-
NPs and antibiotics, streptomycin, gentamicin and cipro-
floxacin, were calculated for both the Gram classes of
bacteria (Table 1). For E. coli 25922, P. aeruginosa 27853,
S. aureus 25923 and S. aureus 49834 strains, the MIC
values of GK-AgNPs were 3.0, 5.0, 5.0 and 5.0 lg/mL,
respectively. The results suggest that among the test
strains, E. coli was found to be more sensitive towards the
bactericidal activity of GK-AgNPs. The obtained MIC
values were used as reference to calculate the FIC index of
antibiotics in combination with GK-AgNPs (Table 1). It
was observed that a concentration of 1 lg/mL of AgNPs in
combination with either 0.25 lg/mL of streptomycin or
0.5 lg/mL of gentamicin or 0.1 lg/mL of ciprofloxacin
was sufficient to inhibit more than 90 % of the bacterial
growth in microtitre plates seeded with 106 CFU/mL, as
compared to the control. For all the test strains, the FIC
index of streptomycin indicated synergistic effect with GK-
AgNPs. While the FIC values of gentamicin and cipro-
floxacin in combination with GK-AgNPs, the effect was
Fig. 1 a TEM micrograph, b SAED pattern, c histogram, and d zeta potential distribution of synthesized GK-AgNPs
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additive. Only with S. aureus 25923, the FIC index of
gentamicin showed synergism with GK-AgNPs. Thus, the
results indicate that the GK-AgNPs have either synergistic
or additive effect with various antibiotics and the extent of
effect depends both on the type of antibiotic and bacterial
strain tested. These results are in concurrence with earlier
studies carried out against spore-forming bacteria with
combination of cinnamaldehyde with silver nanoparticles,
in which at least an additive or near synergistic effect was
observed (Ghosh et al. 2013). It is evident that among the
antibiotics, streptomycin demonstrated highest activity
against both the Gram classes of bacteria with AgNPs, in
terms of synergism. Such an enhancement in antibacterial
activity was earlier reported with streptomycin-loaded
protein-capped gold nanoparticles (Rastogi et al. 2012) and
collective activity of streptomycin and PVP-capped silver
nanoparticles (Kora and Rastogi 2013).
The observations made in the present study have been
compared with contemporary literature in relation to the
enhanced antibacterial action of silver nanoparticles in
combination with various antimicrobial agents. In an ear-
lier synergistic antibacterial study with silver nanoparticles
of 5–40 nm size, MIC values of 30 and 80 lg/mL were
reported for E. coli and S. aureus strains, respectively.
With disk diffusion assay against test strains, the antibac-
terial activities of ampicillin, kanamycin, erythromycin and
chloramphenicol were increased in the presence of AgNPs
(Fayaz et al. 2010). With the same test strains, the com-
bined antibacterial activity of 16 nm sized PVP capped
AgNPs with streptomycin, ampicillin and tetracycline was
enhanced (Kora and Rastogi 2013). The combined efficacy
of ciprofloxacin and gentamicin antibiotics with silver
nanoparticles of 5–30 nm size was reported to be aug-
mented against multidrug-resistant E. coli, P. aeruginosa
and S. aureus strains (Naqvi et al. 2013). In another study
using silver nanoparticles of 32.5 nm, the antifungal
activity of fluconazole was enhanced in the presence of
AgNPs against the test fungi (Fayaz et al. 2010). It is
pertinent to note that all these studies were carried out with
solid agar assays in contrast to broth-based assays used in
the present study. In an earlier broth-based study carried
out with AgNPs of 20 nm size, an MIC value of 40 lg/mL
was reported and the combination of amoxicillin and Ag-
NPs resulted in greater bactericidal efficiency against E.
coli (Ping et al. 2005). The activity of 25–40 nm sized
silver nanoparticles against E. coli, P. aeruginosa and S.
aureus strains was greatly enhanced in micro-broth dilution
method, when utilized in the presence of cinnamaldehyde,
a food grade antimicrobial agent. For the respective strains,
the reported MIC values of AgNPs were 0.6, 6.1 and
3.0 lg/mL. With same ATCC strains used in the present
study; E. coli 25922, P. aeruginosa 27853 and S. aureus
25923, synergistic or near synergistic antibacterial activity
of ampicillin, chloramphenicol and kanamycin were dem-
onstrated with silver nanoparticles of 3 nm size and the
reported MIC values AgNPs were 2.0, 0.5 and 0.5 lg/mL,
respectively (Hwang et al. 2012).
The various degrees of planktonic growth inhibition
induced by GK-AgNPs in combination with various anti-
biotics against used test strains are shown in Fig. 2. For
E. coli 25922 and S. aureus 49834 strains, gentamicin and
ciprofloxacin individually caused higher biofilm inhibition
compared to the KG-AgNPs. Also with P. aeruginosa
Table 1 The antibacterial susceptibility of bacterial strains towards GK-AgNPs and antibiotics in terms of MIC and FIC
Bacterial strain MIC (lg/mL) FIC
GK-AgNPs Streptomycin Gentamicin Ciprofloxacin Streptomycin Gentamicin Ciprofloxacin
E. coli 25922 3.0 1.5 2.0 0.2 0.5 0.65 0.9
P. aeruginosa 27853 5.0 1.0 1.0 0.25 0.45 0.7 0.6
S. aureus 25923 5.0 2.5 2.0 0.2 0.3 0.45 0.7
S. aureus 49834 5.0 1.0 1.0 0.25 0.45 0.7 0.6
Fig. 2 The % inhibition in planktonic growth of different bacterial
strains treated with GK-AgNPs and antibiotics individually and in
combination. Values are mean ± SD for n = 3; *p\ 0.05,
**p\ 0.005, ***p\ 0.001 and ****p\ 0.0001 compared to GK-
AgNPs treated cells
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27853 and S. aureus 25923, ciprofloxacin and gentamicin
showed higher inhibition of biofilm formation than KG-
AgNPs, respectively. Nevertheless, the combination of
KG-AgNPs with all the antibiotics resulted in 95.2, 96.0,
95.5 and 96.2 % growth inhibition for E. coli 25922, P.
aeruginosa 27853, S. aureus 25923 and S. aureus 49834,
respectively.
Inhibition of biofilm formation
The results obtained from the micro-broth dilution assay
were again confirmed from the biofilm inhibition assay
against tested bacterial strains (Fig. 3). As shown in Fig. 2
that 1 lg/mL of AgNPs in combination with either
0.25 lg/mL of streptomycin or 0.5 lg/mL of gentamicin or
0.1 lg/mL of ciprofloxacin was able to significantly inhibit
the biofilm formation in both Gram classes of bacteria. For
Gram-negative E. coli, all the antibiotics individually
caused higher biofilm inhibition compared to the KG-Ag-
NPs. Also with P. aeruginosa 27853 and S. aureus 49834,
gentamicin and ciprofloxacin showed higher inhibition of
biofilm formation than KG-AgNPs. However, the com-
bined activity of both the agents impeded C 70 % of bio-
film formation.
Generation of intracellular ROS
The antibacterial activity of AgNPs was found to be related
to the formation of free radicals. Furthermore, the free
radicals generated by the AgNPs induce bacterial cell
membrane damage which is considered to be the main
cause of cell death. Though the ROS can exist naturally in
intracellular and extracellular locations, under certain
conditions, high levels of ROS can cause oxidative stress in
cells and lead to redox imbalance (Choi and Hu 2008). In
this study, H2DCFDA was used to measure the intracellular
ROS levels after various treatments (Fig. 4). For the cells
treated with GK-AgNPs and streptomycin individually, a
significant increase in ROS levels was observed as com-
pared to the untreated cells. However, the cells treated with
the combination of both GK-AgNPs and streptomycin
showed even higher levels of ROS. The treatment of S.
aureus 49834 cells individually with GK-AgNPs and
streptomycin led to 2.0 and 1.1 fold increase in ROS
generation, while a combined treatment with both the
agents led to 3.0 fold increase in intracellular ROS levels.
Similar pattern of ROS levels was observed for all other
bacterial strains tested, though the fold increase in levels
depended on the type of bacterial strain.
Cytoplasmic potassium ion leakage
The bacterial membrane damage was further confirmed by
quantifying the leakage of cytoplasmic potassium content.
The leakage of cytoplasmic K? has been correlated to the
extent of membrane damage by several researchers (Tiwari
et al. 2008). A significant increase in the levels of K? was
found in cells treated with GK-AgNPs for all the bacterial
strains, when compared to negative and positive controls.
But, the cells treated with streptomycin alone did not
exhibit any considerable increase in the K? levels. When
the cells were exposed to both the GK-AgNPs and strep-
tomycin, the K? levels were higher than the cells treated
Fig. 3 The % inhibition in biofilm formation of different bacterial
strains treated with GK-AgNPs and antibiotics individually and in
combination. Values are mean ± SD for n = 3; *p\ 0.05,
**p\ 0.005, ***p\ 0.001 and ****p\ 0.0001 compared to GK-
AgNPs treated cells
Fig. 4 A bar graph showing the fluorescence intensities of various
bacterial strains due to intracellular ROS generation after exposure
with GK-AgNPs and streptomycin individually and in combination.
Negative and positive controls denote untreated and 70 % ethanol-
treated bacterial cell suspensions. Values are mean ± SD for n = 3;
*p\ 0.05, ***p\ 0.001 and ****p\ 0.0001 compared to negative
control
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with GK-AgNPs alone (Fig. 5). Though streptomycin
alone was not able to cause much leakage of intracellular
K?, still an increase in K? leakage was observed when
combined with AgNPs. The increased oxidative stress can
cause damage not only to cell membrane, but also to pro-
teins, DNA and components of respiratory system which in
turn are responsible for augmented effect offered by GK-
AgNPs and streptomycin combination.
Fluorescence microscopy
The damage to bacterial membrane was also estimated with
Live/dead BacLight kit by differentiating the live and dead
bacteria under fluorescence microscope. The viable cells
with intact membrane were visualized by their green
fluorescence under blue light and the dead cells with
damaged membranes by their red fluorescence under green
light. The fluorescence micrographs of P. aeruginosa
27853 control cells showed numerous intact green colored
viable cells. Whereas, the cells treated with ethanol, GK-
Fig. 5 The intracellular K? leakage of test bacterial strains after
treatment with GK-AgNPs and streptomycin individually and in
combination. Negative and positive controls denote untreated and
70 % ethanol-treated bacterial cell suspensions. Values are
mean ± SD for n = 3; *p\ 0.05 and **p\ 0.005 compared to
negative control
Fig. 6 The fluorescence
micrographs of P. aeruginosa
cells, a Control, b treated with
streptomycin, c treated with
GK-AgNPs and d treated with
GK-AgNPs ? streptomycin
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Ag-NPs and streptomycin showed several intense red col-
ored cells. Further, the cells treated with both GK-AgNPs
and streptomycin showed a higher population of red cells
(Fig. 6). Thus, the fluorescence microscopic analyses
demonstrate a higher cell wall and membrane damage,
leading to an increase in cell death in bacteria treated with
the combination of GK-Ag-NPs and streptomycin.
Evaluation of in vitro cytotoxicity
The biocompatibility of the silver nanoparticles was eval-
uated with HeLa cell line for their use in combination with
antibiotics. HeLa cells were selected for cytotoxic studies
as they are durable, prolific and can be grown very easily in
5 % serum-supplemented standard DMEM medium with
no specific growth component requirement. The % viability
of the cells was plotted against nanoparticles concentration
at 48 h. The concentrations of nanoparticles up to
2.5 lg mL-1 were not cytotoxic. Beyond the concentration
of 2.5 lg/mL, they were cytotoxic and the cell viability
was reduced to 76.5 % and 18.9 % at 5 lg/mL and 10 lg/
mL, respectively (Fig. 7). In the case of doxorubicin-trea-
ted positive control, the viability was reduced to 18.6 %.
Thus, the data suggest that non-cytotoxic concentrations of
antibacterial GK-AgNPs can be used for biomedical and
therapeutic purposes (Ayala-Nu´n˜ez and Villegas 2009).
Conclusions
In this study, we have demonstrated the synergistic
and additive antibacterial effect of GK-AgNPs with
aminoglycosidic and ciprofloxacin antibiotics, respectively,
against both Gram classes of bacteria. It was found that the
extent of enhancement was dependent on both bacterial
strain and type of antibiotic in combination. The results may
pave the way for the combined use of AgNPs and antibiotics
towards decreasing the antibiotic resistance currently
observed for certain bacteria. Research over last several
years has confirmed that nanoscale materials can lead to
unpredicted and abnormal toxicity and hence the dose is
very crucial. Taking care of this point, by standardizing the
concentration of antibiotics, we have shown more than
90 % of bacterial growth inhibition at non-cytotoxic levels
of GK-AgNPs (1 lg/mL). Thus, in combination with anti-
biotics, the antibacterial efficiency and safety of GK-AgNPs
were established for potential in vivo applications.
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